Data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) study, the first and largest clinical trial of pre-symptomatic Alzheimer’s disease, is now widely available to researchers studying the condition.
Comprehensive dataset from A4 study yields key insights about Alzheimer’s disease
- Post author:
- Post published:July 24, 2024
- Post category:uncategorized